AH Capital Management’s Ginkgo Bioworks DNA Stock Holding History

AH Capital Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Hold	108,568	–	–	0.01%	18
2026 Q1	$666K	Hold	108,568	–	–	0.05%	15
2025 Q4	$902K	Hold	108,568	–	–	0.06%	12
2025 Q3	$1.58M	Hold	108,568	–	–	0.11%	11
2025 Q2	$1.22M	Hold	108,568	–	–	0.39%	10
2025 Q1	$619K	Hold	108,568	–	–	0.09%	12
2024 Q4	$1.07M	Hold	108,568	–	–	0.14%	11
2024 Q3	$885K	Sell	108,568 -1	-0%	-$10	0.08%	12
2024 Q2	$1.45M	Hold	108,569	–	–	0.12%	11
2024 Q1	$5.04M	Buy	+108,569	New	+$5.62M	0.36%	11

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

AH Capital Management's DNA Position: Q2 2026 in Review

AH Capital Management held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 108,568 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #18.

AH Capital Management first reported a position in DNA in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.04M in Q1 2024. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

AH Capital Management held 108,568 shares of Ginkgo Bioworks worth $1.08M as of Q2 2026.
AH Capital Management left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up 0.01% of AH Capital Management's portfolio in Q2 2026, its #18 holding.
AH Capital Management first reported a position in Ginkgo Bioworks in Q1 2024 and has held it in 10 quarters since.
AH Capital Management's Ginkgo Bioworks position peaked at $5.04M in Q1 2024.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on AH Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.